Manufacturing

FDA halts Nurix’s cancer drug over manufacturing

Nurix’s B-cell cancer drug on partial hold by FDA over manufacturing issues

Anika Sharma

Nurix Therapeutics has temporarily halted a phase 1 trial for its B-cell malignancy drug, NX-2127, as it undertakes a manufacturing ...

RLS expands CDMO services for radiopharma | Pharma News

RLS to offer CDMO services for radiopharma at 8 US locations

Anika Sharma

The biopharmaceutical landscape is witnessing a seismic shift towards radiopharmaceuticals, with major players like Eli Lilly making substantial investments, exemplified ...

Novo Nordisk Foundation Cellerator, Cell therapy development and manufacturing, Stem cell therapies for chronic diseases, Cellerator Technical University of Denmark, Cellerator public and private clients, Cellerator funding and timeline, Cellerator cell therapy types and services,

Novo Nordisk Foundation Cellerator to boost cell therapy development and production in Denmark

Anika Sharma

The Novo Nordisk Foundation is embarking on a mission to establish a pivotal “hub” within the cell therapy ecosystem by ...

Moderna, COVID-19 booster, vaccine, low demand, manufacturing

Moderna to cut down COVID booster production amid low demand: Reuters reports

Anika Sharma

While the FDA and the Centers for Disease Control and Prevention (CDC) have given their green light to updated COVID ...

Moderna to research and manufacture mRNA meds in China under $1B agreement

Moderna to research and manufacture mRNA meds in China under $1B agreement

SG Tylor

Despite ongoing political tensions between the United States and China, foreign investments in the pharmaceutical sector are progressing in China. ...